EthAum Zero BS Healthcare Revenue Scaler Program

EthAum Venture Partners, a Singapore-based deep tech revenue scaler and fund, runs the EthAum Zero BS Healthcare Revenue Scaler Program. This 16-week hybrid accelerator is built for post-prototype healthcare and medical AI startups that want to turn their technology into a revenue-generating, investment-ready business. The program's central goal is to accelerate market entry and drive measurable revenue growth, backed by EthAum's global healthcare network spanning Singapore, India, Japan, Hong Kong, the Middle East, and the UK.

Participants receive a SAFE investment of up to USD 2 million (approx. ₹16.6 crore) and pilot funding of up to USD 50,000 (approx. ₹41.5 lakh) to run initial trials with hospitals and enterprise customers. Beyond the cash, the 16-week hybrid accelerator includes intensive go-to-market (GTM) support, mentorship from healthcare and GTM experts, pilot opportunities with major hospitals, investor introductions, and practical workshops like 'startup roast sessions' to sharpen pitches and strategies. After the core 16 weeks, startups continue to receive ecosystem support for up to four more years, covering customer acquisition, market penetration, and fundraising assistance.

EthAum has backed over 120 portfolio startups. While its broader fund is sector-agnostic, this specific program is dedicated to healthcare innovations such as Medical AI, Hospital Digitalization, Life Sciences, Surgery, and Hospital Operations. The program typically selects startups seeking to raise USD 500K–1M and showing monthly revenues between USD 10K and USD 500K, positioning them for Series A funding. Applications are accepted on a rolling basis, with the next cohort expected to begin in August 2025. EthAum's 'Zero BS' approach focuses on tangible, measurable outcomes rather than generic advice.

• Up to $2 Million SAFE Investment
• Up to $50,000 Pilot Funding
• 16-week Hybrid Accelerator
• 4 Years of Extended GTM Support
• 1-10% Equity Taken (Pre-money)
• Open to India, Singapore, Japan, Taiwan, UK, Middle East

This program is open to incorporated startups that have built a prototype, demonstrated user traction, or already have paying customers. The startup must operate in healthcare, medical AI, hospital digitalization, life sciences, surgery, or hospital operations. Funding stage should be between Angel and Series A, with the startup typically seeking to raise USD 500K–1M. Monthly revenue must fall between USD 10K and USD 500K. Geographically, startups from India, Singapore, Japan, Taiwan, the United Kingdom, and the Middle East can apply.

EthAum Zero BS Healthcare Revenue Scaler Program is open to startups at any stage. It is open to startups registered anywhere in India.

EthAum Zero BS Healthcare Revenue Scaler Program accepts applications on a rolling basis — there is no fixed cut-off date, so eligible startups can apply at any time. Because rolling programmes can pause without notice, confirm the window is still open on the official site before you start.

Selected startups receive a SAFE investment of up to USD 2 million (approx. ₹16.6 crore), providing growth capital without an immediate valuation. Additionally, they are eligible for pilot funding of up to USD 50,000 (approx. ₹41.5 lakh) to support initial hospital and enterprise pilots. Beyond direct funding, the program offers a 16-week hybrid accelerator followed by four years of post-program ecosystem support, including expert mentorship, customer acquisition strategies, market access facilitation, and introductions to a global network of investors, CXOs, and healthcare partners.

EthAum Zero BS Healthcare Revenue Scaler Program is offered by EthAum Venture Partners. It is delivered directly by EthAum Venture Partners as a equity. You can verify current details and timelines on the provider's official website before applying.

Applications are reviewed by the EthAum team, including venture associates, managing partners, and venture analysts. The initial screening evaluates alignment with the healthcare and medical AI focus, stage (post-prototype, user traction, or paying customers), revenue metrics, and potential for global scalability. Shortlisted startups may be invited for deeper engagement, such as interviews, detailed presentations, and discussions with EthAum's healthcare and GTM experts. Final selection prioritizes startups with strong innovation, market fit, a capable team, and a clear path to leveraging EthAum's ecosystem for revenue growth and investment.

Before you apply to EthAum Zero BS Healthcare Revenue Scaler Program, keep the following documents ready:

• A pitch deck or short business plan describing the problem, product and traction
• Company registration documents and PAN
• Founder identification (PAN / Aadhaar) and brief profiles
• Recent financial statements or projections
• Product details — a demo, prototype or working link if available

Exact requirements are confirmed on the official application portal — treat this as a preparation checklist.

EthAum Zero BS Healthcare Revenue Scaler Program is best suited for startups in India seeking an equity investment of ₹16.6Cr. If that describes your startup, review the eligibility criteria above before applying.